title: Spectacular evolution of reactive arthritis after early treatment with infliximab.
authors.forename: Marie
authors.initials: M
authors.lastname: Thomas-Pohl
authors.forename: Axelle
authors.initials: A
authors.lastname: Tissot
authors.forename: Frédéric
authors.initials: F
authors.lastname: Banal
authors.forename: Dominique
authors.initials: D
authors.lastname: Lechevalier
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use; D016918:Arthritis, Reactive / Q000188:drug therapy* / Q000209:etiology*; D006801:Humans; D000069285:Infliximab; D055985:Latent Tuberculosis / Q000150:complications*; D008297:Male; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors; D014777:Virus Diseases / Q000150:complications*
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab